AAP IMPLANTATE AG O.N. overview

EQS-Ad-hoc: aap Implantate AG / Key word(s): AGM/EGM aap Implantate AG: resolves to convene an Annual General Meeting to elect a new auditor 03-Dec-2024 / 20:22 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The Management Board of aap Implantate AG (the " Company" ) today resolved to convene a General Meeting to...

EQS-Ad-hoc: aap Implantate AG / Key word(s): Change in Forecast aap Implantate AG: EBITDA guidance raised 18-Nov-2024 / 20:12 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The Management Board of aap Implantate AG (" Company ") informs today about the increase of the guidance of the EBITDA target. The Company...

EQS-News: aap Implantate AG / Key word(s): Bond aap informs about the actual status of the mandatory convertible bond 2023-2028 06.11.2024 / 23:39 CET/CEST The issuer is solely responsible for the content of this announcement. aap Implantate AG (" aap " or "Company") informs that as of October 31, 2024, conversion rights in the amount of 97.4% of the mandatory convertible bond issued in October 2023 were exercised in the context of elective conversions. This means that only 2.6% of the...

EQS-Ad-hoc: aap Implantate AG / Key word(s): Capital Increase aap Implantate AG: Cash capital increase and intended non-cash capital increase 22-Oct-2024 / 16:15 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The Management Board of aap Implantate AG (" Company ") today resolved, with the approval of the Supervisory...

EQS-Ad-hoc: aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG: Step-by-step restart of IT systems 18-Oct-2024 / 22:14 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. aap Implantate AG (the “ Company ”) announces with reference to the ad hoc release published on October 15, 2024 at 11:25 p.m....

EQS-Ad-hoc: aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG: Possible cyber attack on aap 15-Oct-2024 / 23:25 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. aap Implantate AG (the “ Company ”) determined that there may have been a cyber attack on the Company's IT systems. In response, the Company...

EQS-News: aap Implantate AG / Key word(s): Regulatory Admission/Miscellaneous Progress in the MDR process - important MDR initial certification audit carried out 07.10.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. aap Implantate AG (" aap " or "Company") has reached another important milestone in the transition from MDD (Medical Device Directive 93/42/EEC) to MDR (Medical Device Regulation EU 2017/745). In the week from 9 September 2024 to 13...

EQS-News: aap Implantate AG / Key word(s): Study/Study results Very successful human clinical trial with the innovative antibacterial surface-treated implants receives approval for quick end of recruitment. 24.09.2024 / 22:15 CET/CEST The issuer is solely responsible for the content of this announcement. BfArM and lead ethics committee approve early end of recruitment Last patient included on 6 August 2024; A total of 202 patients were included in the study; Start of the MDR registration phase...